Volume 10, Number 11—November 2004
Research
Histopathologic Improvement with Lymphedema Management, Léogâne, Haiti
Susan F. Wilson*, Jeannette Guarner*, Alix L. Valme†, Jacky Louis-Charles†, Tara L. Jones*, and David G. Addiss*
Table 4
Demographic, physical, and treatment-related characteristics of 27 patients with initial and follow-up skin biopsy specimens, by degree of histologic improvement (involving >4 vs. <4 histologic characteristics), Léogâne, Haiti
| Factors examined | Improvement in >4 histologic characteristics | Improvement in <4 histologic characteristics |
|---|---|---|
| Number of patients | 11 | 16 |
| Female (%) | 9 (82) | 11 (69) |
| Median age, y (range) | 39 (20–61) | 32 (16–61) |
| Stage of lymphedema (%) | ||
| Stage 1 | 2 (18) | 0 (0) |
| Stage 2 | 5 (45) | 13 (81) |
| Stage 3 | 4 (36) | 3 (19) |
| Median no. of days in lymphedema management before 1st biopsy (range) | 21 (0–432) | 19.5 (0–468) |
| Median no. of days between biopsies (range) | 359 (317–503) | 366 (317–656) |
| Median annual incidence of ADLA between biopsies (range) | 0 (0–2) | 0 (0–3) |
| Median duration of lymphedema, y (range) | 11.5 (4–27) | 7 (0–25) |
